H. Lukka

Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis.

M. Johnston, A. Fyles, G. Browman, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Combined gamma‐irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin

G. Singh, A. Rainbow, H. Lukka, 2004, International journal of radiation biology.

Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment.

G. Singh, A. Rainbow, H. Lukka, 1999, International journal of radiation biology.

MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL

D. Low, H. Sandler, J. Michalski, 2019, Journal of Urology.

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

Peter Chang, B. Reeve, H. Sandler, 2014, Journal of the National Cancer Institute.

Determination of human skin pain threshold using 27 MHz radiofrequency heating.

D. Pye, P. Nélis, H. Lukka, 1988, The British journal of radiology.